Multidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohnʼs Disease
Authors:
- 1 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 19 (1) , 141-150
Abstract
Background. Escherichia coli is increasingly implicated in the pathogenesis of ileal Crohn's disease (ICD), offering a potential therapeutic target for diseaseKeywords
This publication has 54 references indexed in Scilit:
- Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- Pathogenic agents in inflammatory bowel diseasesCurrent Opinion in Gastroenterology, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileumThe ISME Journal, 2007
- Mycobacteria and Crohn's disease: The endless storyDigestive and Liver Disease, 2007
- Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunitiesInflammatory Bowel Diseases, 2006
- Sero-Reactivity to Microbial Components in Crohn's Disease Is Associated with Disease Severity and Progression, but not NOD2/CARD15 GenotypeAmerican Journal of Gastroenterology, 2004
- Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's diseaseGastroenterology, 1995
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991